S396-0294 Screening compound: N-(5-chloro-2-methoxyphenyl)-2-[1-(1-methyl-6-oxo-1,6-dihydropyridazin-4-yl)piperidin-3-yl]acetamide

S396-0294 Screening compound: N-(5-chloro-2-methoxyphenyl)-2-[1-(1-methyl-6-oxo-1,6-dihydropyridazin-4-yl)piperidin-3-yl]acetamide
S396-0294 Screening compound: N-(5-chloro-2-methoxyphenyl)-2-[1-(1-methyl-6-oxo-1,6-dihydropyridazin-4-yl)piperidin-3-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S396-0294
N-(5-chloro-2-methoxyphenyl)-2-[1-(1-methyl-6-oxo-1,6-dihydropyridazin-4-yl)piperidin-3-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S396-0294

Molecular Formula

C19H23ClN4O3 (C19 H23 ClN4 O3)

Compound Name

N-(5-chloro-2-methoxyphenyl)-2-[1-(1-methyl-6-oxo-1,6-dihydropyridazin-4-yl)piperidin-3-yl]acetamide

IUPAC name

N-(5-chloro-2-methoxyphenyl)-2-[1-(1-methyl-6-oxo-16-dihydropyridazin-4-yl)piperidin-3-yl]acetamide

SMILES

CN1N=CC(N2CC(CC(Nc(cc(cc3)Cl)c3OC)=O)CCC2)=CC1=O

InChI

InChI=1S/C19H23ClN4O3/c1-23-19(26)10-15(11-21-23)24-7-3-4-13(12-24)8-18(25)22-16-9-14(20)5-6-17(16)27-2/h5-6,9-11,13H,3-4,7-8,12H2,1-2H3,(H,22,25)/t13-/m1/s1

InChI Key

BAIFPSBKSLJMDT-CYBMUJFWSA-N

MDL Number (MFCD)

MFCD29003507

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

390.87

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.155

Distribution Coefficient, logD

1.913

Water Solubility, LogSw

-3.22

Polar Surface Area

62.188

Acid Dissociation Constant (pKa)

9.00

Base Dissociation Constant (pKb)

7.25

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

42.10

S396-0294 in Drug Discovery

Included in Screening Libraries

Ligand-Gated Ion Channels Library (3887 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

Peptidomimetic Library (37031 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Eye
Targets:
  • Ion Channels
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with S396-0294 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S396-0294?
Check Price and Availability of S396-0294, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S396-0294 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S396-0294
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S396-0294
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S396-0294 available by request